Suchergebnisse - "Shimazu, Yosuke"

PubPharm (26)

1

A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell-of-origin dependent effects of H3K27M

enthalten in: Glia | 2022

von Tomita, Y. | Shimazu, Y. | Somasundaram, A. | +11

2

Genomic Profiling of a Case of Glioneuronal Tumor with Neuropil-like Islands

enthalten in: Acta medica Okayama | 2022

von Tsuboi, N. | Ishida, J. | Shimazu, Y. | +8

3

Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis

enthalten in: PloS one | 2022

von Hattori, Y. | Kurozumi, K. | Otani, Y. | +12

4

A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M

enthalten in: Glia | 2022

von Tomita, Y. | Shimazu, Y. | Somasundaram, A. | +11

5

Pyogenic Ventriculitis After Anterior Skull Base Surgery Treated With Endoscopic Ventricular Irrigation And Reconstruction Using a Vascularized Flap

enthalten in: Acta medica Okayama | 2021

von Tomita, Y. | Shimazu, Y. | Kawakami, M. | +9

6

Combination of Ad-SGE-REIC and Bevacizumab Modulates Glioma Progression by Suppressing Invasion and Angiogenesis

enthalten in: ResearchSquare.com | 2021

von Hattori, Y. | Kurozumi, K. | Otani, Y. | +10

7

Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

enthalten in: Acta neuropathologica communications | 2021

von Uneda, A. | Kurozumi, K. | Fujimura, A. | +12

8

Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

enthalten in: Acta Neuropathologica Communications | 2021

von Uneda, A. | Kurozumi, K. | Fujimura, A. | +12

9

Neurosurgery for brain metastasis from breast cancer

enthalten in: Translational cancer research | 2020

von Tomita, Y. | Kurozumi, K. | Fujii, K. | +2

10

Study protocol of a Phase I/IIa clinical trial of Ad-SGE-REIC for treatment of recurrent malignant glioma

enthalten in: Future oncology (London, England) | 2020

von Kurozumi, K. | Fujii, K. | Shimazu, Y. | +7